Related Experiment Video
Updated: Aug 8, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
G-quadruplex-enhanced circular single-stranded DNA (G4-CSSD) adsorption of miRNA to inhibit colon cancer progression
Haidong Wu1, Weilong Zhong2, Ronghua Zhang3
1Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs and Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.
Background:
Chromosomal heterogeneity leads to the abnormal expression and mutation of tumor-specific genes. Drugs targeting oncogenes have been extensively developed. However, given the random mutation of tumor suppressor genes, the development of its targeted drugs is difficult.
Methods:
Our early research revealed that artificial circular single-stranded DNA (CSSD) can restore multiple tumor suppressor genes to inhibit tumor malignant progression by adsorbing miRNA. Here, we improved CSSD to a fully closed single-stranded DNA with G quadruplex DNA secondary structure (G4-CSSD), which made G4-CSSD with higher acquisition rate and decreased degradation. The Cancer Genome Atlas (TCGA) and Human Protein Atlas database were used to predict tumour suppressor genes in colon cancer. Cellular and animal experiments were performed to validate the role of G4-CSSD in cancer cell progression.
Results:
In colon cancer, we observed the simultaneous low expressions of chloride channel accessory 1 (CLCA1), UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (B3GNT6) and UDP glucuronosyltransferase family 2 member A3 (UGT2A3), which indicated an favourable prognosis. After repressing miR-590-3p with G4-CSSD590, the upregulation of CLCA1, B3GNT6 and UGT2A3 inhibited the proliferation and metastasis of colon cancer cells.
Conclusions:
This study may provide basis for new treatment methods for colon cancer by restoration of tumor suppressor genes.
Insights
This study introduces G4-CSSD, a novel DNA structure that restores tumor suppressor genes to inhibit colon cancer progression. By targeting miR-590-3p, it upregulates key genes, reducing cancer cell proliferation and metastasis.
Area of Science:
- Genomics and Molecular Biology
- Cancer Research
- Biotechnology
Background:
- Tumorigenesis is driven by chromosomal heterogeneity, affecting oncogene and tumor suppressor gene expression.
- Targeted therapies for oncogenes are established, but developing drugs for randomly mutated tumor suppressor genes remains challenging.
- Early research demonstrated artificial circular single-stranded DNA (CSSD) can restore tumor suppressor gene function by adsorbing microRNA (miRNA).
Purpose of the Study:
- To develop an improved CSSD, termed G4-CSSD, with enhanced stability and efficacy for cancer therapy.
- To investigate the potential of G4-CSSD in restoring tumor suppressor gene function and inhibiting colon cancer progression.
- To identify and validate key tumor suppressor genes and their regulatory miRNAs in colon cancer.
Main Methods:
- G4-CSSD was designed as a fully closed single-stranded DNA incorporating a G quadruplex secondary structure.
- The Cancer Genome Atlas (TCGA) and Human Protein Atlas databases were utilized to identify potential tumor suppressor genes in colon cancer.
- In vitro and in vivo experiments were conducted to assess the efficacy of G4-CSSD in colon cancer models.
Main Results:
- Simultaneous low expression of CLCA1, B3GNT6, and UGT2A3 was correlated with favorable prognosis in colon cancer.
- G4-CSSD590 effectively repressed miR-590-3p, leading to the upregulation of CLCA1, B3GNT6, and UGT2A3.
- The restoration of these tumor suppressor genes significantly inhibited colon cancer cell proliferation and metastasis.
Conclusions:
- G4-CSSD represents a promising therapeutic strategy for colon cancer by restoring tumor suppressor gene function.
- This approach offers a novel avenue for developing targeted treatments for cancers with compromised tumor suppressor genes.
- Further research into G4-CSSD could lead to new clinical interventions for colon cancer patients.
Related Concept Videos
MicroRNAs
Experimental RNAi

